Introduction: Shanghai Hyundai Hasen (Shangqiu) Pharmaceutical Co., Ltd. is a production enterprise controlled by Shanghai Hyundai Pharmaceutical Co., Ltd., with more than 800 employees, total assets of 654.38 billion yuan, 654.38+020 pharmaceutical preparations and 654.38+06 raw materials, and annual production of 65.438+05 billion small-volume injections and 654.38+ oral tablets. Our company has the world's most advanced three production lines for small-volume injections I, II and III. Oral solid preparations include tablets, capsules and granules, and the raw materials are 16. All dosage forms and workshops of our company have passed the national GMP certification and obtained the GMP certificate issued by the US Food and Drug Administration. The products meet the requirements of China Pharmacopoeia (CP), British Pharmacopoeia (BP), European Pharmacopoeia (EP) and American Pharmacopoeia. Our products sell well in 26 provinces, municipalities and autonomous regions, and are exported to Southeast Asia, Latin America, Oceania, Africa and Europe. "Quality first, customer first" is the creed of Shanghai Hyundai Hasen Pharmaceutical Co., Ltd., "Pursuing Excellence and striving for first-class" is the service tenet of modern Hasen people, and modern Hasen cares about life. Every employee treats the quality and brand of the enterprise just like caring for life. Taking quality as life and health as the foundation embodies the unremitting pursuit and desire of modern Hassan people.
Legal Representative: Jiang Zhengxiang.
Established:1999-11-12.
Registered capital: 83.29 million yuan.
Industrial and commercial registration number: 41140010008151.
Type of enterprise: other limited liability companies
Company address: No.66, North Xinxing Road, Zhenxing Road West, liangyuan district, Shangqiu.